NObreath regulatory update

The U.K.'s NICE issued draft guidance recommending Niox Mino and Niox Vero from Aerocrine AB (SSE:AERO, Solna, Sweden) and NObreath from Bedfont Scientific to help diagnose eosinophilic asthma. The tests are recommended for use in subjects who, after initial clinical examination, are considered to have an intermediate probability of having asthma and when a trial of bronchodilator reversibility testing is intended as part of the diagnosis. Additionally, the 3 CE Marked tests are recommended to support the management of symptomatic asthma in subjects whose symptoms are being treated with inhaled corticosteroids. ...